Papers in Molecular Biomedicine
Page 2 · newest first
- Bariatric surgery may alleviate MASLD by restoring mitochondria-lipid droplet structural and functional integrity through suppression of the Mitochondrial Fission Factor-Perilipin 5 axisMolecular Biomedicine · 2026
- Characterization of SPP1 + macrophages and their correlation with resistance to neoadjuvant chemotherapy in colorectal cancer liver metastasisMolecular Biomedicine · 2026
- Targeting the CD4+ effector memory T cells re-expressing CD45RA suppressor galectin-7: a multi-omics-guided therapeutic strategy for idiopathic pulmonary fibrosisMolecular Biomedicine · 2026
- Oncolytic virus encoding decorin and the CD40 ligand boosts T-cell response and achieves a durable antitumor response during breast cancer treatmentMolecular Biomedicine · 2026
- Bile acid signaling in health and diseaseMolecular Biomedicine · 2026
- Precision base-editing of the cryptic 3’ acceptor site to correct the RNA splicing defect of β654-thalassemiaMolecular Biomedicine · 2026
- SGLT2 inhibitors: mechanisms, physiology and pharmacology, and clinical applicationsMolecular Biomedicine · 2026
- mRNA lipid nanoparticle vaccines: current status, challenges and future prospectsMolecular Biomedicine · 2026
- MFSD2A in health and disease: lysolipid transport, barrier physiology, and translational boundariesMolecular Biomedicine · 2026
- Aryl hydrocarbon receptor is involved in DNA damage repair after liver injury with diethylnitrosamine in miceMolecular Biomedicine · 2026
- Troponin: biology, molecular mechanisms, and multidimensional clinical applicationsMolecular Biomedicine · 2026
- Roles of inflammation and metabolic dysfunction in cardiovascular diseases: molecular mechanisms and therapeutic targetsMolecular Biomedicine · 2026
- Fine-tuning the lysine-arginine duet: a dietary approach to suppress tumor growthMolecular Biomedicine · 2026
- The DCBLD2 super-enhancer drives colorectal cancer progression through FOSL2/JUND-mediated activation of the CD146/AKT/TNFRSF6B pathwayMolecular Biomedicine · 2026
- Craniofacial development: genetics, signaling pathways, teratogenic mechanisms, and clinal significanceMolecular Biomedicine · 2026
- Ovarian tumor domain-containing protein 1 deficiency attenuates metabolic dysfunction-associated steatotic liver disease by promoting the ubiquitination of HSP90α in hepatocytesMolecular Biomedicine · 2026
- Extracellular signal-regulated kinase 3 forms a nuclear complex with Aly/REF export factor and the splicing factor proline and glutamine rich to exacerbate pathological cardiac remodeling due to pressure overloadMolecular Biomedicine · 2026
- CRISPR/dCas9-induced upregulation of endogenous apolipoprotein A1 and paraoxonase 1 genes reduces the aortic lipid deposits in apoE−/− miceMolecular Biomedicine · 2026
- Induction of transferrin receptor 1-mediated ferroptosis by ultrasound-triggered microbubble destruction sensitizes glioblastoma to radiotherapyMolecular Biomedicine · 2026
- Transcriptome-based epigenetic screening identifies DNA hypermethylation signatures as prognostic biomarkers in oral squamous cell carcinomaMolecular Biomedicine · 2026
- Cardiac fibrosis: mechanistic insights and translational advancesMolecular Biomedicine · 2026
- Betaine-driven Keap1 methylation promotes p62-mediated autophagy and Nrf2 stabilization to alleviate glutathione-dependent redox dyshomeostasis in liver injuryMolecular Biomedicine · 2026
- Decoding neuro-tumor interactions in pancreatic cancer: mechanisms, immunosuppressive networks and therapeutic opportunitiesMolecular Biomedicine · 2026
- Nasopharyngeal carcinoma: epidemiology, risk factors, signaling pathways, clinical features, diagnosis, and managementMolecular Biomedicine · 2026
- Extracellular vesicles in targeted drug delivery: from biological functions to surface engineeringMolecular Biomedicine · 2026
- 177Lu-trastuzumab radionuclide therapy: a promising strategy for trastuzumab-resistant brain metastases in HER2+ breast cancerMolecular Biomedicine · 2026
- HDCA suppresses exosomal lncRNA MSTRG171708 release to inhibit Treg-mediated immunometabolism in hepatocellular carcinomaMolecular Biomedicine · 2026
- Neuroimmune interactions: from molecular mechanisms to therapeutic targetsMolecular Biomedicine · 2026
- Extracellular vesicles for next-gen therapeutics and drug deliveryMolecular Biomedicine · 2026
- Liquid biopsy: current applications and future directionsMolecular Biomedicine · 2026
- Lysine-specific demethylase 3A (KDM3A) protects against ovarian dysfunction in premature ovarian insufficiency by transcriptional activation of ATP-binding cassette sub-family A member 7 (ABCA7)-mediated mitochondrial homeostasisMolecular Biomedicine · 2026
- The ubiquitin-editing enzyme A20 (TNFAIP3): mechanisms of activation, biological function, diseases and therapeutic targetsMolecular Biomedicine · 2026
- A cfDNA fragmentomics classifier for noninvasive differentiation of benign and malignant renal massesMolecular Biomedicine · 2026
- The type I FLT3 inhibitor XL999 overrides secondary FLT3-ITD mutations that arise under gilteritinib and quizartinib treatment in acute myeloid leukemiaMolecular Biomedicine · 2026
- Tertiary lymphoid structures in cancer: their development, composition, clinical prognosis, and the drivers of the anti-tumor responsesMolecular Biomedicine · 2026
- A dimeric mRNA vaccine based on key-mutant and KP.3 RBDs induces broad-spectrum immunity and protects mice against JN.1 and XDV challengesMolecular Biomedicine · 2026
- Artificial intelligence and ultra-high performance computing methods and experiments for drug discovery: virtual screening, deep learning, molecular dynamics simulations, ADMET modelling, and experimental validationMolecular Biomedicine · 2026
- Solute Carrier Family 1 Member 5 (SLC1A5)-dependent glutamine transport regulates macrophage senescence and efferocytosis during liver regenerationMolecular Biomedicine · 2026
- A late-stage multi-dimensional intervention rescues lethal viral pneumonia in an aged hamster modelMolecular Biomedicine · 2026
- A peroxiredoxin 1–reactive oxygen species feedback loop modulates nuclear factor kappa B activity in osteoclastogenesisMolecular Biomedicine · 2026
- PARP inhibitor YCH1899 activates type I interferon signaling and synergizes with STING agonists in BRCA-proficient tumorsMolecular Biomedicine · 2026
- Exceptional treatment responses and molecular markers among 103 colorectal cancer cell linesMolecular Biomedicine · 2026
- Lactate metabolism and protein lactylation in inflammatory and tumor microenvironmentsMolecular Biomedicine · 2026
- Twist Family BHLH Transcription Factor 1 orchestrates hypoxia-lactate crosstalk to bridge glycolytic flux and tubular maladaptation in fibrotic kidneysMolecular Biomedicine · 2026
- Silencing arachidonate 15-lipoxygenase alleviates hypoxia-induced cognitive impairment through the mediation of phospholipase A2 group IVC–LPC18:0 to suppress ferroptosisMolecular Biomedicine · 2026
- miR-486-5p suppresses autophagy in hepatocellular carcinoma via activation of the AKT/mTOR signalling pathwayMolecular Biomedicine · 2026
- Applications of synthetic biology in biomedicineMolecular Biomedicine · 2026
- Pathological depositions in human disease: converging mechanisms in atherosclerosis, Alzheimer's disease, and related disordersMolecular Biomedicine · 2026
- Piezo1 channel: structure, mechanogating mechanism, functions, diseases and therapeutic strategyMolecular Biomedicine · 2026
- Deletion of Pleiotrophin protects against high-fat diet-induced liver metabolic disease, independently of the sexual dimorphism in dietary responseMolecular Biomedicine · 2026